Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin aspart: a review.

David Owens1, Jiten Vora

  • 1Diabetes Research Unit, First Floor, Academic Centre, Llandough Hospital, Penlarn Road, Penarth, South Glamorgan, CF64 2FX, Wales, UK. owens dr@cf.ac.uk

Expert Opinion on Drug Metabolism & Toxicology
|October 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intraoperative Neuromonitoring and Electrophysiological Nerve Stimulation for the Spinal Accessory and Marginal Mandibular Nerve During Neck Dissection: A Scoping Review.

The Journal of laryngology and otology·2026
Same author

Spraying Cry1A.105 + Cry2Ab2 Bt sweet corn has marginal benefit for Helicoverpa zea (Lepidoptera: Noctuidae) suppression.

Journal of economic entomology·2026
Same author

Beyond the Cuff: State-of-the-Art on Cuffless Blood Pressure Monitoring.

Sensors (Basel, Switzerland)·2026
Same author

New paths to attenuate the burden of hypoglycaemia in type 1 diabetes.

Diabetes, obesity & metabolism·2026
Same author

Successful Treatment of Portal Cavernoma Cholangiopathy With Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt (TIPS).

Cureus·2025
Same author

Should glycaemic variability and times spent in levels 1 and 2 hypoglycaemia be revised downward in type 1 diabetes treated with advanced systems of insulin delivery?

Diabetes, obesity & metabolism·2025
Same journal

The use of natural language processing in predictive toxicology.

Expert opinion on drug metabolism & toxicology·2026
Same journal

An update on beta-lactam-beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant gram-negative pathogens.

Expert opinion on drug metabolism & toxicology·2026
Same journal

Optimizing tamoxifen therapy in breast cancer: a narrative review of dose escalation in patients with CYP2D6 polymorphisms.

Expert opinion on drug metabolism & toxicology·2026
Same journal

Effect of concomitant rifampin and clarithromycin on elexacaftor-tezacaftor-ivacaftor using a physiologically based pharmacokinetic (PBPK) modeling approach.

Expert opinion on drug metabolism & toxicology·2026
Same journal

Gastrointestinal bleeding risk among antithrombotics users: a propensity score matched study of drug classes.

Expert opinion on drug metabolism & toxicology·2026
Same journal

Complex <i>in vitro</i> model developers' perspective on advanced hepatic <i>in vitro</i> culture methods for predictive drug safety.

Expert opinion on drug metabolism & toxicology·2026
See all related articles

Insulin aspart offers faster glucose lowering and better post-meal sugar control than human insulin for diabetes management. Its shorter action reduces risks of low blood sugar, making it a valuable option, even during pregnancy.

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Insulin aspart is a rapid-acting insulin analogue.
  • Diabetes management requires effective glucose control, particularly postprandially.
  • Comparison with human soluble insulin is essential for understanding analogue benefits.

Purpose of the Study:

  • To compare the pharmacokinetic and pharmacodynamic profiles of insulin aspart and human soluble insulin.
  • To evaluate the efficacy of insulin aspart in controlling postprandial hyperglycemia.
  • To assess the safety profile, including hypoglycemia risk, of insulin aspart.

Main Methods:

  • Subcutaneous injection of insulin aspart and human soluble insulin.
  • Measurement of plasma insulin concentrations.
  • Assessment of glucose-lowering effects and glycemic control.

Related Experiment Videos

  • Evaluation of hypoglycemia incidence.

    • Main Results:

    • Insulin aspart demonstrated faster absorption and higher peak plasma concentrations compared to human soluble insulin.
    • Insulin aspart provided superior control of postprandial hyperglycemia.
    • A shorter duration of action for insulin aspart was observed, correlating with reduced interprandial and nocturnal hypoglycemia.
    • Insulin aspart is suitable for continuous subcutaneous insulin infusion and pregnancy.

    Conclusions:

    • Insulin aspart offers a faster and more effective glucose-lowering action than human soluble insulin.
    • Its improved postprandial glycemic control and reduced hypoglycemia risk present significant advantages.
    • Insulin aspart is a valuable therapeutic option for diabetes, including use in pregnancy and continuous infusion therapy.